Astrazeneca Pharma India Ltd.

₹9381.0

Astrazeneca Pharma India Ltd.

Add Alert
Add Watchlist

₹9381.0

₹9381.0

-33.5 (-0.36%) - 7 Oct 2025 04:21 PM

About Company

AstraZeneca Pharma India Limited (AZPIL) is the operating company and covers manufacturing, sales and marketing activities of the company in India. It is a listed company and is a subsidiary of AstraZeneca Plc, UK. The company is committed to deliver life-changing medicines to patients through innovative science and global excellence in development and commercialization. The company has an innovative portfolio in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology and respiratory. Rated as one of the finest in South East Asia, AstraZeneca’s Indian manufacturing facility has a sophisticated production facility designed to meet the most stringent international standards, conforming to WHO cGMP (current Good Manufacturing Practices) norms. The facility is an ISO 14001 certified company and has a full-fledged environment management system in place.

Market Cap. ₹ 23,452 Cr.
52 Week - High/Low ₹ 10,691/6,220
P/E Ratio 127.91
P/B Ratio 30.44
Enterprise Value ₹ 23,075 Cr.
ROE % 15.73
RSI Value 63.08
EMA 50 8934.81
EMA 200 8312.22
Market Cap. ₹ 23,452 Cr.
52 Week - High/Low ₹ 10,691/6,220
P/E Ratio N/A
P/B Ratio N/A
Enterprise Value -
ROE % N/A
RSI Value 63.08
EMA 50 8934.81
EMA 200 8312.22

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.